Omnicell, Inc. Stock Analysis & AI Score
Omnicell, Inc. (OMCL) has an ST Score of 53.1 (B-), driven by its Profitability (A) and held back by its Growth (D+). Analysts rate it Hold with a $56.67 price target (+71.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Omnicell, Inc. (OMCL) has an ST Score of 53.1 (B-), driven by its Profitability (A) and held back by its Growth (D+). Analysts rate it Hold with a $56.67 price target (+71.6% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthD+
All factor grades
- ProfitabilityA
- ForecastB+
- Financial StrengthC+
- MomentumC-
- ValuationD+
- GrowthD+
- Piotroski8/9
Contact
OMCL stock: frequently asked questions
What is OMCL's ST Score?
Omnicell, Inc. (OMCL) has an ST Score of 53.1 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is OMCL a buy, hold, or sell?
Analysts rate OMCL a Hold, with a price target of $56.67 (+71.6% vs the current price). Our ST Score grades it B- (53.1/100). The ST Score is a data-driven signal, not a recommendation.
What are OMCL's factor grades?
Valuation D+, Profitability A, Financial Strength C+, Momentum C-, Growth D+, Forecast B+.
What is OMCL's valuation grade?
Omnicell, Inc. (OMCL) earns a valuation grade of D+, measured against Medical - Healthcare Information Services peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is OMCL's growth grade?
Omnicell, Inc. (OMCL) earns a growth grade of D+, measured against Medical - Healthcare Information Services peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is OMCL's profitability grade?
Omnicell, Inc. (OMCL) earns a profitability grade of A, measured against Medical - Healthcare Information Services peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is OMCL's financial strength grade?
Omnicell, Inc. (OMCL) earns a financial strength grade of C+, measured against Medical - Healthcare Information Services peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for OMCL?
The average analyst price target for Omnicell, Inc. (OMCL) is $56.67 from 19 analysts, which is +71.6% versus the recent price of $33.03.
What is OMCL's Piotroski score?
Omnicell, Inc. (OMCL) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.